PolyActiva is an Australian-based biotechnology company that has developed a platform technology to deliver drugs to specific sites in the body. The polymeric prodrugs can take various forms, including rod-shaped implants, injectable gels and topical films and the rate of drug delivery can be controlled for up to 12 months.

Biotechnology

PolyActiva

Russell Tait

James Williams

Ingmar Wahlqvist

Caitlin Gladman

Justine Walter

Andrew Donohue

The Research and Development team at PolyActiva focuses on creating and refining polymeric prodrugs for targeted drug delivery systems. They work on developing and optimizing drug delivery mechanisms such as rod-shaped implants, injectable gels, and topical films, ensuring controlled release rates that can last up to 12 months. The team combines rigorous analytical research with innovative development to enhance therapeutic efficacy and patient outcomes.

Research and Development

About

Team members